Hims & Hers PAO sells 5,529 shares under plan

Hims & Hers Health, Inc. PAO Irene Becklund completed an open-market sale of 5,529 shares of Class A Common Stock at $24.69 per share.

Rhea-AI Filing Summary

Hims & Hers Health, Inc. PAO Irene Becklund completed an open-market sale of 5,529 shares of Class A Common Stock at $24.69 per share. After this transaction, she directly holds 8,752 shares. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on November 5, 2025, indicating it was scheduled in advance rather than timed discretionarily.

Insider Trade Summary 10b5-1

Net Seller: 5,529 shares

Net Sell 1 txn

Insider Becklund Irene

Role PAO

Sold 5,529 shs ($137K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	5,529	$24.69	$137K

Holdings After Transaction: Class A Common Stock — 8,752 shares (Direct)

Footnotes (1)

1. F1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2025 by the Reporting Person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HIMS PAO Irene Becklund report on this Form 4?

Irene Becklund reported an open-market sale of 5,529 Hims & Hers Class A Common Stock shares. The transaction was executed at a price of $24.69 per share and is documented as a non-derivative sale on the reported transaction date.

At what price did HIMS insider Irene Becklund sell her shares?

She sold 5,529 shares at $24.69 per share. This reflects an open-market sale of Hims & Hers Class A Common Stock, recorded as a standard non-derivative transaction in the Form 4 filing for the stated transaction date.

How many HIMS shares does Irene Becklund hold after the reported sale?

After the sale, she directly holds 8,752 shares of Hims & Hers Class A Common Stock. This post-transaction balance is disclosed in the Form 4 and represents her remaining direct ownership following the 5,529-share disposition.

Was the HIMS insider sale by Irene Becklund made under a Rule 10b5-1 plan?

Yes, the sale was carried out under a Rule 10b5-1 trading plan adopted on November 5, 2025. Such plans pre-schedule trades, indicating the timing of this transaction was arranged in advance rather than decided spontaneously.

What type of transaction code is used for Irene Becklund’s HIMS share sale?

The transaction is coded “S,” indicating a sale in an open market or private transaction. The Form 4 classifies it as a non-derivative disposition of Class A Common Stock rather than an option exercise, gift, or tax-withholding event.

Does the Form 4 show any derivative positions for HIMS insider Irene Becklund?

No derivative transactions or remaining derivative positions are listed for her in this Form 4. The filing only reports a single non-derivative open-market sale of Class A Common Stock, along with the updated direct share balance following the trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 04:17 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Becklund Irene

(Last) (First) (Middle)

2269 CHESTNUT STREET, #523

(Street)

SAN FRANCISCO CALIFORNIA 94123

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Hims & Hers Health, Inc. [ HIMS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PAO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/17/2026		S(1)		5,529	D	$24.69	8,752	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 5, 2025 by the Reporting Person.

Remarks:

	/s/ Kimberly Mather, Attorney-in-Fact for Irene Becklund	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)